TWA
LABD icon

TCI Wealth Advisors’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

TCI Wealth Advisors’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1
Closed -$207 – 1286
2023
Q1 		$207 Hold
1
– – ﹤0.01% 2335
2022
Q4 		$172 Hold
1
– – ﹤0.01% 2350
2022
Q3 		$0 Buy
+1
New +$232 ﹤0.01% 2436
2022
Q2 		– Hold
0
– – – 2406
2022
Q1 		– Hold
0
– – – 2342
2020
Q3 		– Sell
-1
Closed – – 1593
2020
Q2 		$0 Buy
+1
New +$1.26K ﹤0.01% 1568
2020
Q1 		– Sell
-1
Closed -$1K – 1637
2019
Q4 		$1K Buy
+1
New +$3.55K ﹤0.01% 1370
2017
Q4 		– Hold
0
– -$2K – 1396
2017
Q3 		– Hold
0
– – – 962
2017
Q2 		– Hold
0
– – – 1158

Other funds holding LABD

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCI Wealth Advisors's LABD Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2023, closing a stake of 1 share — an estimated $207 sold.

TCI Wealth Advisors first reported a position in LABD in Q4 2019 and held it in 5 quarters. The position peaked at $1K in Q4 2019. 19 funds tracked by Wall St. Rank hold LABD as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 1 Direxion Daily S&P Biotech Bear 3X ETF share in Q2 2023, an estimated $207.
  • TCI Wealth Advisors first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q4 2019 and held it in 5 quarters.
  • TCI Wealth Advisors's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $1K in Q4 2019.
  • 19 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.